Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. The claudin family characteristics in pan-cancer and the role of claudin12 in the malignant progression of lung adenocarcinoma.Scientific reports · 2025
   Article
2. Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.Virology journal · 2024
   Article
3. Novel roles for HMGA2 isoforms in regulating oxidative stress and sensitizing to RSL3-Induced ferroptosis in prostate cancer cells.Heliyon · 2023
   Article
4. Differential Expression of Claudin in Odontogenic Cysts.European journal of dentistry · 2022
   Article
5. MiR-3571 modulates the proliferation and migration of vascular smooth muscle cells by targeting claudin 1.International journal of medical sciences · 2022
   Article
6. Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins.Frontiers in cell and developmental biology · 2020
   Review
7. CLDN10 promotes a malignant phenotype of osteosarcoma cells via JAK1/Stat1 signaling.Journal of cell communication and signaling · 2019
   Article
8. Claudin-9 enhances the metastatic potential of hepatocytes via Tyk2/Stat3 signaling.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2019
   Article
9. Increased expression of claudin-17 promotes a malignant phenotype in hepatocyte via Tyk2/Stat3 signaling and is associated with poor prognosis in patients with hepatocellular carcinoma.Diagnostic pathology · 2018
   Article
10. CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway.Cancer cell international · 2018
    Article
11. Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling.Gut · 2014
    Article
12. Emerging roles of claudins in human cancer.International journal of molecular sciences · 2013
    Review
13. Role of ABL family kinases in cancer: from leukaemia to solid tumours.Nature reviews. Cancer · 2013
    Review
14. Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.PloS one · 2013
    Article

Corrections and comments

• Erratum for
  Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells.2013

Authors and funding

12 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.